Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The document concludes that the endoscopic brow lift is a less invasive cosmetic surgery that requires careful technique and patient selection to achieve lasting, aesthetically pleasing results.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document explains various skin conditions and their treatments.

Royal jelly can protect the heart from damage caused by paclitaxel.

Combining fractional CO2 laser and PRP is very effective for treating female hair loss.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

New therapies are being developed that target integrin pathways to treat various diseases.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

More plasma leptin means higher baldness risk in men.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

About 40% of women without hair loss and 60% with hair loss experience a lot of hair shedding, especially those under 50 with long hair.

PRP shows promise for short-term hair growth, especially in young men.